Literature DB >> 1937879

Inflammatory processes in asthma.

J Bousquet1, P Chanez, A M Campbell, J Y Lacoste, R Poston, I Enander, P Godard, F B Michel.   

Abstract

Bronchial inflammation is a characteristic of asthma, but, although postmortem and rare bronchoscopic studies had been performed, it is only after 1980 that many experiments were done. Electron microscopy, immunohistochemistry and molecular biology have enhanced our knowledge. As bronchial biopsies and bronchoalveolar lavage present drawbacks, it is favorable to combine both to obtain the best insights into inflammation. The epithelium is rarely intact in asthmatic patients, the cells being both 'fragile' and activated. Eosinophil inflammation is highly important and likely involved in the damage of the epithelium and submucosa. Airway macrophages and monocytes are present in greater amounts and are activated in the bronchi, and they are certainly involved in the pathogenesis of asthma. Mast cells are activated and some emphasis has been put on lymphocytes. Therefore, asthma appears to be a desquamative bronchitis with mixed cell infiltrate.

Entities:  

Mesh:

Year:  1991        PMID: 1937879     DOI: 10.1159/000235367

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  3 in total

1.  Endothelial cell prostaglandin I(2) and platelet-activating factor production are markedly attenuated in the calcium-independent phospholipase A(2)beta knockout mouse.

Authors:  Janhavi Sharma; John Turk; Jane McHowat
Journal:  Biochemistry       Date:  2010-07-06       Impact factor: 3.162

2.  Platelet-activating factor stimulates eicosanoid production in cultured feline tracheal epithelial cells.

Authors:  T Wu; R D Rieves; C Logun; J H Shelhamer
Journal:  Lung       Date:  1995       Impact factor: 2.584

3.  Effect of KOB03, a polyherbal medicine, on ovalbumin-induced allergic rhinitis in guinea pigs.

Authors:  Hyo Won Jung; Jin Ki Jung; Young Ho Kim; Jong-Seong Kang; Yong-Ki Park
Journal:  Chin Med       Date:  2012-12-20       Impact factor: 5.455

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.